Modulation of adipose tissue derived stem cells encapsulated in injectable multi-functional hydrogels by Coutinho, Daniela F. et al.
TS043
Modulation of adipose tissue derived stem cells
encapsulated in injectable multi-functional
hydrogels
DF Coutinho1,2, VE Santo1,2, SG Caridade1,2, JF Mano1,2,
NM Neves1,2, ME Gomes1,2 and RL Reis1,2
13B’s Research Group – Biomaterials, Biodegradables and
Biomimetics, University of Minho, Headquarters of the European
Institute of Excellence on Tissue Engineering and Regenerative
Medicine, AvePark, Taipas, Guimara˜es, Portugal;
2ICVS/3B’s – PT Government Associate Laboratory, Braga/
Guimara˜es, Portugal
Objective: The cellular microenvironment plays an important role in
controlling the cellular behavior. Therefore, in Tissue Engineering strat-
egies, systems have been designed so that by combining cells, signaling
molecules and engineered substrates, one can mimic as closely as possi-
ble the native microenvironment of the extracellular matrix. In this
context, injectable hydrogels have been developed that allow control-
ling the cellular spatial distribution and that provide a 3D support.
However, many of these systems fail to replicate the mechanical prop-
erties of tissues and more significantly to provide a cell-friendly envi-
ronment. Therefore, the aim of this study is to evaluate the cellular
response of human adipose stem cells (hACS) within a growth factor-
enriched injectable hydrogel.
Methods: Hydrogels were formed by combining platelet lysates (PLs)
with a methacrylated gellan gum (MeGG) solution at different ratios.
The hydrogels were further stabilized by photopolymerization. The
parameters of photocrosslinkingwere varied and thedynamicalmechan-
ical properties evaluated for all the conditions. Total protein content
released from the hydrogels was quantified for all the conditions using
micro-BCA assay. Human ASCs were both seeded on the surface of the
hydrogels for 7 days and encapsulatedwithin thematerials for 14 days.
Results and Discussion: Hydrogels with tunable mechanical properties
were fabricated by changing the volume ratio of PLs and MeGG. The
highest elastic modulus (nearly 500 kPa) was achieved for the condi-
tion with the lowest volume of PLs (2MeGG:1PLs), being significantly
more elastic than MeGG alone. The rate of release of proteins present
in the PLs from the PLs-MeGG hydrogels was higher for the condition
with equal volume of MeGG and PLs (1MeGG:1PLs), as a result of the
lower crosslinked polymer network. Human ASCs cultured onto the
engineered surfaces showed a good metabolic activity and prolifera-
tion. Immunostaining revealed that MeGG:PL combinations fostered
the attachment and spreading of cells. A strikingly improved cellular
behavior was observed for the formulations with PLs, when compared
to MeGG alone. This behavior was further confirmed at a 3D scale,
demonstrated by a significantly higher cellular metabolic activity on
the hydrogels with PLs.
Conclusion: Our system combines the mechanical support from MeGG
with the biological cues from PLs to engineer a cell-friendly injectable
hydrogel with tunable mechanical properties. Given the simplicity in
producing these rather enriched hydrogels, we envision that it may be
beneficial for various tissue engineering and regenerative medicine
applications.
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During the past decades, marine organisms have been the focus of con-
siderable attention as potential source of valuable materials. For
instance, chitosan is a biopolymer with high potential in the biomedical
field and can be produced from crustacean shells and squid pens [1]. In
this sense, we propose the use of chitosan to produce scaffolds for
regenerative medicine purposes. An alkaline solution was used to de-
proteinize squid pens and isolate b-chitin (Chaussard 2004), which was
further converted into chitosan through a deacetylation reaction. Chito-
san was then processed into porous structures by freeze-drying [3],
where chitosan solutions (4%)were submitted to different freezing tem-
perature of -80 !C and -196 !C. The produced structures were further
submitted to neutralization methods with 4% NaHO, including in some
cases a pre-washing step using ethanol/water solutions (100:0; 90:10,
80:20; 70:30 and 50:50) [4]. The morphology of scaffolds produced
using either squid or commercial chitosan revealed a lamellar structure,
independent of the source and/or freezing temperature. All chitosan
scaffolds produced exhibited no-cytotoxic behaviour over L929 cells. To
test the in vitro functionality of the scaffolds, cells from the mouse chon-
drogenic cell line ATDC-5 were seeded in the scaffolds and cultured for
different time periods. Scaffolds made from squid chitosan were shown
to promote better cell adhesion than commercial chitosan scaffolds and
comparable or better cell proliferation. This demonstrates that squid
chitosan is a valuable alternative to produce scaffolds for different appli-
cations in regenerative medicine, namely the regeneration of cartilage.
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